Efficacy of subcutaneous tocilizumab in patients with rheumatoid arthritis and systemic sclerosis overlap syndrome: a report of two cases and review of the literature

Efficacy of subcutaneous tocilizumab in patients with rheumatoid arthritis and systemic sclerosis overlap syndrome: a report of two cases and review of the literature

Abstract Background The details of two rheumatoid arthritis (RA) patients with systemic sclerosis (SSc) who were administered tocilizumab, an anti-interleukin-6 receptor antibody, are reported, along with a review of the literature. Case presentation Two RA patients with SSc with inadequate response...

Full description

Bibliographic Details
Main Authors: Hiroki Wakabayashi, Hitoshi Kino, Makoto Kondo, Keiichi Yamanaka, Masahiro Hasegawa, Akihiro Sudo
Format: Article
Language:English
Published: BMC 2019-04-01
Series:BMC Rheumatology
Subjects:
Rheumatoid arthritis
Systemic sclerosis
Interleukin-6
Tocilizumab
Online Access:http://link.springer.com/article/10.1186/s41927-019-0063-x

Internet

http://link.springer.com/article/10.1186/s41927-019-0063-x

Similar Items